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Introduction: Amyloidosis is characterized by extracellular deposition of abnormal insoluble fibrils, which cause
structural and functional disorders. Amyloidosis is classified into primary and secondary disease. We report a case
of localized amyloidosis of the urinary bladder. In the English literature, this is the first case effectively treated with
occlusive dressing therapy using dimethyl sulfoxide.
Case presentation: A 58-year-old Japanese woman was introduced to our department with asymptomatic gross
hematuria. Cystoscopy revealed a gently raised nodule at the right lateral wall. Histopathological findings of this
lesion revealed extensive amorphous eosinophilic deposits that stained positive with Congo red and Dylon. The
patient was diagnosed with primary localized amyloidosis of the urinary bladder. To treat residual amyloidosis of
the bladder, we performed occlusive dressing therapy using dimethyl sulfoxide. After treatment, cystoscopy and
magnetic resonance imaging showed no relapse of the mass-like lesion of the bladder wall.
Conclusions: Occlusive dressing therapy using dimethyl sulfoxide is efficacious and tolerable for amyloidosis of the
urinary bladder. The maneuver of occlusive dressing therapy was simpler and easier than that of intravesical
instillation, and occlusive dressing therapy was advantageous in that the patient could perform the therapy herself
every day. However, invasive surgical management including cystectomy should be considered if conservative
management is inefficacious.
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Amyloidosis is a heterogenous group of diseases that share
the common feature of extracellular deposition of an in-
soluble fibrillar protein in organs and tissues. Amyloidosis
can also be classified as primary or secondary disease. The
primary type (AL amyloidosis) is associated with an
underlying immune dyscrasia, including multiple myeloma
or Waldenström’s macroglobulinemia. In the secondary
type (AA amyloidosis), an underlying chronic inflamma-
tory disease often arises as a complication. Primary local-
ized amyloidosis of the urinary bladder is a rare condition
with approximately 200 reported cases in the literature* Correspondence: uroltateki@yahoo.co.jp
1Department of Urology, JA Onomichi General Hospital, 1-10-23 Hirahara,
Onomichi, Hiroshima 722-0018, Japan
Full list of author information is available at the end of the article
© 2013 Yoshino et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or[1-3]. The clinical presentation and cystoscopic appear-
ance of this condition are known to mimic bladder cancer.
Case presentation
A 58-year-old Japanese woman was introduced to our
department with asymptomatic gross hematuria. Her
past medical history was unremarkable. There was no
history of urinary symptoms and urinary tract infection.
The results of a physical examination were unremark-
able. Urinalysis showed microscopic hematuria and no
pyuria. Urine cytology indicated atypical cells. A cystos-
copy revealed a gently raised nodule with erythema at
the right lateral wall (Figure 1). Contrast-enhanced mag-
netic resonance imaging (MRI) at 3.0 tesla also indicated
thickness of the right lateral wall (Figure 2), which was
suspected for muscle invasion of bladder cancer.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Cystoscopic findings showed a gently raised nodule
with erythema at the right lateral wall (arrows).
a
b
Figure 3 Histopathological findings of the specimens revealed
extensive extracellular amorphous eosinophilic deposits in the
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bladder lesions. Histopathological findings of all the
specimens revealed extensive extracellular amorphous
eosinophilic deposits in the subepithelial layer (Figure 3)
that stained positive with Congo red and Dylona
b
Figure 2 Magnetic resonance imaging findings of the pelvis
(a: coronal section, b: transverse section). Magnetic resonance
imaging indicated thickness of the right lateral wall of the urinary
bladder (arrow).
subepithelial layer. Hematoxylin and eosin stain, a: ×40, b: ×200.(Figure 4). Furthermore all specimens showed retention
of congophilic staining when treated with potassium per-
manganate, consistent with primary (AL) amyloid.
This was followed by biopsies of the stomach, duode-
num and rectum, all of which were negative for amyloid.
There was no Bence-Jones proteinuria, and serum or
urine protein electrophoresis did not reveal any mono-
clonal band. Therefore, the patient was diagnosed with
primary localized amyloidosis of the urinary bladder.
To treat residual amyloidosis of the bladder, we
performed occlusive dressing therapy (ODT) using di-
methyl sulfoxide (DMSO) every day. After percutaneous
administration of DMSO, regression of the bladder le-
sions as well as improvement of gross hematuria were
achieved. Five years after the initiation of treatment,
cystoscopy and MRI showed no relapse of the mass-like
lesion of the bladder wall. Currently, DMSO is adminis-
tered every few days as maintenance therapy.
Discussion
Amyloidosis is characterized by the extracellular depos-
ition of proteins. Amyloidosis may be primary or sec-
ondary depending on whether it is due to underlying
immune dyscrasia or secondary to a chronic inflamma-
tory disorder. Although systemic amyloid can occur any-
where in the urinary tract, including the kidney, renal
ab
Figure 4 Immunohistochemical analysis showed positive
staining at eosinophilic deposits. a: Congo red stain ×200,
b: Dylon stain ×200.
Figure 5 Clinical photograph of the occlusive dressing therapy
using dimethyl sulfoxide. The gauze impregnated with 7mL of
50% dimethyl sulfoxide solution was attached to the skin of the
patient’s thigh which was covered with cling wrap.
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amyloidosis of the urinary bladder is a rare urological
disease [4-6].
Amyloidosis of the urinary bladder affects males and
females equally in about the fifth and sixth decades of life.
Previous studies have reported gross painless hematuria as
the most common presentation and have stated that the
remaining patients present with irritative voiding symp-
toms [4-6]. Primary amyloidosis of the urinary bladder
assumes clinical importance because it clinically masque-
rades as a malignancy as in the present case.
Histological examination of the lesion is mandatory
for diagnosis. Typically, primary amyloidosis deposits are
superficially beneath the surface mucosa, sometimes
extending into the superficial smooth muscle of the
urinary bladder. In secondary amyloidosis, the amyloid
tends to accumulate in the bladder vasculature thus
explaining why secondary amyloidosis with diffuse blad-
der involvement has a high mortality of 30% with its po-
tential for massive hemorrhage [7].
Management of primary amyloidosis of the urinary blad-
der is mainly transurethral resection of the bladder if it is
localized. Medical treatments such as intravesical instilla-
tion of DMSO have also been tried with limited success.
DMSO is a dipolar solvent, which has a molecular
weight of 78.13. DMSO has the action of penetranceacceleration, local anesthetic effect, sedative action and
anti-inflammatory effect as pharmacological action. The
penetrance action of DMSO is characteristic and it passes
with a high concentration quickly through a skin barrier.
Isobe [8] reported that when 90% DMSO solution was
applied to human skin, it was identified in the blood
5 minutes later, and maximum blood concentration was
obtained 4 to 6 hours later. In addition, this plateau was
reported to last 36 to 72 hours [8]. The internal use, appli-
cation to the skin and enema administration have been
tried successfully since the efficacy of DMSO for amyloid-
osis was reported by Osserman et al. in 1976 [9].
To the best of our knowledge, this is the first case in
the English literature of localized amyloidosis of the
urinary bladder effectively treated with ODT using
DMSO. Previous Japanese literature has also reported
the efficacy and tolerability of ODT using DMSO for
amyloidosis of the urinary bladder [10-12]. In our case,
in accordance with previous reports [10-12], the gauze
of the ODT was dipped in a setup 7mL dose of 50%
DMSO solution. The gauze impregnated with the solu-
tion was attached to the skin of the patient’s thigh,
which was covered with cling wrap for about 2 hours
every day (Figure 5).
The intravesical instillation of DMSO has already been
established in the treatment of amyloidosis of the urinary
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euver was considered to be a fault. The maneuver of ODT
was simpler and easier than that of intravesical instillation,
and ODT was advantageous in that the patient could her-
self make the ODT every day. In the present case, no
severe side effects were observed and the treatment com-
pliance of the case was good. Because there was no
established theory about the duration of DMSO-ODT, the
DMSO was administered every few days as maintenance
therapy in our case. From now on we will extend intervals
of administration gradually, monitoring for relapse of
amyloidosis. There were less than 10 reported cases
treated with ODT using DMSO for amyloidosis of the
urinary bladder. Therefore, there is a need to accumulate
data and demonstrate the optimum method of administra-
tion (concentration of solution, volume, application time)
and the optimum duration of treatment.
In localized amyloidosis of the urinary tract, despite a
few reports of recurrence, the prognosis is comparatively
good. In addition, there were few cases of amyloidosis of
the urinary bladder that required invasive surgical manage-
ment such as cystectomy. Therefore, we think that conser-
vative medical management such as ODT using DMSO
should be tried first, leading to bladder preservation.
Invasive surgical management including cystectomy
should be considered only if conservative management
such as ODT using DMSO for several months does not
induce a reduction of the bladder mass or improve gross
hematuria.
Conclusions
ODT using DMSO is efficacious and tolerable for amyl-
oidosis of the urinary bladder. The maneuver of ODT
was simpler and easier than that of intravesical instilla-
tion. However, invasive surgical management including
cystectomy should be considered if conservative man-
agement is inefficacious.
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